Pneumonia
consolidation of alveoli or infiltration of the intestinal tissue with inflammatory cells or both.
Cause - 0-2 month- stepttococcus, staphylococcus,staphylococcus aureus , listerai E-coli, H ifluenza, s. pneumonia
- 2-6 month-RSV(respiratiory system virus), Hinfluenza, chlamydia, s.pneumonial,streptococuss aureus, influenza virus
- 6 month -5yrs -RSV, parainfluenza,H influenza,Adeno virus
- >5yrs-mycoplasma chlamydia, H infuenza
Risk factor
- Low birth wt
- Malnutrition
- Vit A deficiency
- Passive smoking
- Air polution
S/s
- Fever
- Chest pain
- Tachypnea
- Respiratory distress
Complication
- Empyemia lung abscess
- pneumthorax
Diagnosis(WHO)
- Children younger than 2 months: Greater than or equal to 60 breaths/min
- Children aged 2-11 months: Greater than or equal to 50 breaths/min
- Children aged 12-59 months: Greater than or equal to 40 breaths/min
Investigation
- TC
- DC
- ESR
- Hb%
- Platelate
- CRP
- CR
- BLD- c/s
- Decrease WBC
Treatment
Oral
Amoxycilin
Dosing & Uses
Pediatric
Dosing Forms & Strengths
Ear, Nose, & Throat Infections
Mild to moderate infections
Severe infections
Tonsillitis/Streptococcal pharyngitis
Spectrum of action
- α- and β-hemolytic Streptococcus, S pneumoniae, Staphylococcus, H influenzae
Acute Otitis Media
>40 kg: 500 mg PO q12hr or 250 mg PO q8hr for 10-14 days
Lower Respiratory Tract Infections
Mild, moderate, or severe infections
Spectrum of action
- α- and β-hemolytic Streptococcus, S pneumoniae, Staphylococcus, H influenzae
Gonorrhea
Acute, uncomplicated anogenital or urethral infections
Spectrum of action
- N gonorrhoeae
Anthrax
Postexposure inhalational prophylaxis
>40 kg: 500 mg PO q8hr
80 mg/kg/day PO divided q8hr for 4 weeks (with concomitant vaccine) or for 60 days (without vaccine)
Infective Endocarditis
Prophylaxis
Dosing & Uses
Adult
Dosing Forms & Strengths
Ear, Nose, & Throat Infections
Mild to moderate infections
- 500 mg PO q12hr or 250 mg PO q8hr for 10-14 days
Severe infections
- 875 mg PO q12hr or 500 mg PO q8hr for 10-14 days
Tonsillitis/pharyngitis
- Moxatag: 775 mg PO qDay for 10 days, taken within 1 hour after finishing a meal
Spectrum of action
- α- and β-hemolytic Strep, S pneumoniae, Staph spp, H influenzae
Genitourinary Tract Infections
Mild to moderate infections
- 500 mg PO q12hr or 250 mg PO q8hr
Severe infections
- 875 mg PO q12hr or 500 mg PO q8hr
Spectrum of action
- E coli, P mirabilis, or E faecalis
Skin & Skin Structure Infections
Mild to moderate infections
- 500 mg PO q12hr or 250 mg PO q8hr
Severe infections
- 875 mg PO q12hr or 500 mg PO q8hr
Spectrum of action
- α- and β-hemolytic Strep, Staph spp, E coli
Tonsilitis
775 mg (ER tabs) PO qDay for 10 days
Lower Respiratory Tract Infections
875 mg PO q12hr or 500 mg PO q8hr for 10-14 days
Spectrum of action
- α- and β-hemolytic Strep, S pneumoniae, Staph spp, H influenzae
Helicobacter Pylori
H pylori infection and active or 1-year history of duodenal ulcer
Triple therapy
- 1 g PO q12hr for 14 days with lansoprazole (30 mg) and clarithromycin (500 mg)
Dual therapy
- 1 g PO q8hr for 14 days with lansoprazole (30 mg) in patients intolerant of, or resistant to, clarithromycin
Gonorrhea
Acute, uncomplicated anogenital or urethral infections
3 g PO once as a single dose
Spectrum of action
- N gonorrhoeae
Anthrax
Postexposure inhalational prophylaxis
500 mg PO q8hr
Infective Endocarditis
Prophylaxis
2 g PO 30-60 min before procedure
Cotrimoxazole
(trimethoprim/sulfamethoxazole (Rx) )
Dosing & Uses
Pediatric
Dosing Forms & Strengths
Serious Infections
<2 months: Contraindicated
Acute Otitis Media
Acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae
<2 months: Contraindicated
Pneumocystis (Carinii) Jiroveci Pneumonia
<2 months: Contraindicated
Shigellosis
<2 months: Contraindicated
Urinary Tract Infection
<2 months: Contraindicated
Skin/soft Tissue Infection Due to Community Acquired MRSA (Off-label)
4-6 mg TMP/kg/dose PO q12hr for 5-10 days; add beta-lactam antibiotic to regimen if beta-hemolytic Streptococcuts spp also suspected
Dosing & Uses
Adult
Dosing Forms & Strengths
Chronic Bronchitis
Acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae
DS tablet: 1 PO q12h for 10-14 days
Pneumocystis (Carinii) Jiroveci Pneumonia
Documented Pneumocystis jiroveci pneumonia (PCP); also, prophylaxis against PCP in individuals who are immunosuppressed
Prophylaxis
- Tablet: 80-160 mg TMP PO qDay or 160 mg TMP 3 times/week on consecutive or alternate days
Shigellosis
Enteritis caused by susceptible strains of Shigella flexneri and S sonnei
DS tablet: 1 tab PO q12hr for 5 days
Traveler's Diarrhea
Traveler's diarrhea due to susceptible strains of enterotoxigenic Escherichia coli
DS tablet: 1 tab PO q12hr for 5 days
Urinary Tract Infections
UTIs caused by susceptible strains of Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis, and Proteus vulgaris
Pyelonephritis: 1 DS tab or 2 regular-strength tabs PO q12hr x 14 days
Prostatitis: 1 DS tab or 2 regular-strength tabs PO q12hr x 14 days or 2-3 months if chronic infection
A 3-day course may be used for acute, uncomplicated cystitis
Prophylaxis (off-label): Various regimens exist; may use regular-strength tablet once/twice per week
Acne Vulgaris (Off-label)
1 DS tab or 1 regular-strength tab PO qDay or q12hr for up to 18 weeks
Community Acquired Pneumonia (Off-label)
1 DS tab PO q12hr for 10-14 days
- penicillin-I/V or
- Ampicilin+gentamycin-I/V or
- Cefotaxim+Flucloxacillin-I/V* 7dys
supportive
- Paracetamol
- Oxygen and fluid maintenance
- Monitor vital regularly
- Broncho dilator if needed
- Salbutamol- Normal
- Aminophyline-severe I/V
No comments:
Post a Comment